Due to a dosing cup problem, New Jersey-based drug maker Wyeth on Monday announced a U.S.-wide voluntary recall and replacement program of several nonprescription cold medicines.
The products -- Robitussin Cough DM, Robitussin Cough & Cold CF, Robitussin Cough & Congestion, Robitussin Head & Chest Congestion PE, Robitussin Cough Sugar Free DM, and Children's Dimetapp Cough & Congestion -- come with dosing caps that don't mark the half-teaspoon level recommended for children ages 2 to 5, the Associated Press reported.
Wyeth said consumers with children ages 2 to 5 should not use these products until replacement products with a new dosage cup are available. These products will start appearing on store shelves in early November but it will take a few months to replace the several million products currently in circulation.
No injuries related to the dosing cup issue have been reported and there is no reason for consumers to seek a refund, Wyeth spokesman Doug Petkus told the AP.